|
|
||||||||
Correspondence to:
John Y. L. Chiang
Fibrates are widely used hypolipidemic drugs that regulate the expression of many genes involved in lipid metabolism by activating the peroxisome proliferator-activated receptor
These results suggest that PPAR
Supplementary key words:
bile acid synthesis, gallstones, peroxisome proliferators, hypolipidemic drugs, cytochrome P450, HNF-4
Copyright © 2000 by Lipid Research, Inc.
Original Article
Peroxisome proliferator-activated receptor
Maria Marrapodia and
John Y. L. Chianga
(PPAR
) and agonist inhibit cholesterol 7
-hydroxylase gene (CYP7A1) transcription
a Department of Biochemistry and Molecular Pathology, Northeastern Ohio Universities College of Medicine, P.O. Box 95, Rootstown, OH 44272-0095
(PPAR
). The objective of this study was to investigate the mechanism of action of peroxisome proliferators and PPAR
on the transcription of cholesterol 7
-hydroxylase, the rate-limiting enzyme in the conversion of cholesterol to bile acids in the liver. When cotransfected with the expression vectors for PPAR
and RXR
, Wy14,643 reduced human and rat cholesterol 7
-hydroxylase gene (CYP7A1)/luciferase reporter activities by 88% and 43%, respectively, in HepG2 cells, but not in CV-1 or CHO cells. We have mapped the peroxisome proliferator response element (PPRE) to a conserved sequence containing the canonical AGGTCA direct repeats separated by one nucleotide (DR1). This DR1 sequence was mapped previously as a binding site for the hepatocyte nuclear factor 4 (HNF-4) which stimulates CYP7A1 transcription. Electrophoretic mobility shift assay (EMSA) showed no direct binding of in vitro synthesized PPAR
/RXR
heterodimer to the DR1 sequence. PPAR
and Wy14,643 did not affect HNF-4 binding to the DR1. However, Wy14,643 and PPAR
/RXR
significantly reduced HNF-4 expression in HepG2 cells.
and agonist repress cholesterol 7
-hydroxylase activity by reducing the availability of HNF-4 for binding to the DR-1 sequence and therefore attenuates the transactivation of CYP7A1 by HNF- 4.Marrapodi, M., and J. Y. L. Chiang. Peroxisome proliferator-activated receptor
(PPAR
) and agonist inhibit cholesterol 7
-hydroxylase gene (CYP7A1) transcription. J. Lipid Res. 2000. 41: 514;520. ![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Sun, L. Zhang, H. F. Gu, W. Han, M. Ren, F. Wang, B. Gong, L. Wang, H. Guo, W. Xin, et al. Peroxisome Proliferator-Activated Receptor-{alpha} Regulates the Expression of Pancreatic/Duodenal Homeobox-1 in Rat Insulinoma (INS-1) Cells and Ameliorates Glucose-Induced Insulin Secretion Impaired by Palmitate Endocrinology, February 1, 2008; 149(2): 662 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. van der Hoogt, W. de Haan, M. Westerterp, M. Hoekstra, G. M. Dallinga-Thie, J. A. Romijn, H. M. G. Princen, J. W. Jukema, L. M. Havekes, and P. C. N. Rensen Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression J. Lipid Res., August 1, 2007; 48(8): 1763 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, O. Mezei, and N. F. Shay Human and Murine Hepatic Sterol-12-{alpha}-Hydroxylase and Other Xenobiotic Metabolism mRNA Are Upregulated by Soy Isoflavones J. Nutr., July 1, 2007; 137(7): 1705 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Luci, B. Giemsa, H. Kluge, and K. Eder Clofibrate causes an upregulation of PPAR-{alpha} target genes but does not alter expression of SREBP target genes in liver and adipose tissue of pigs Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R70 - R77. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Woods, J. P. Vanden Heuvel, and I. Rusyn Genomic Profiling in Nuclear Receptor-Mediated Toxicity Toxicol Pathol, June 1, 2007; 35(4): 474 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shin, I. Kim, Y. Inoue, S. Kimura, and F. J. Gonzalez Regulation of Mouse Hepatic {alpha}-Amino-beta-Carboxymuconate-{epsilon}-Semialdehyde Decarboxylase, a Key Enzyme in the Tryptophan-Nicotinamide Adenine Dinucleotide Pathway, by Hepatocyte Nuclear Factor 4{alpha} and Peroxisome Proliferator-Activated Receptor {alpha} Mol. Pharmacol., October 1, 2006; 70(4): 1281 - 1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, B. Christian, and D. B. Jump Regulation of Rat Hepatic L-Pyruvate Kinase Promoter Composition and Activity by Glucose, n-3 Polyunsaturated Fatty Acids, and Peroxisome Proliferator-activated Receptor-{alpha} Agonist J. Biol. Chem., July 7, 2006; 281(27): 18351 - 18362. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Miao, S. Fang, Y. Bae, and J. K. Kemper Functional Inhibitory Cross-talk between Constitutive Androstane Receptor and Hepatic Nuclear Factor-4 in Hepatic Lipid/Glucose Metabolism Is Mediated by Competition for Binding to the DR1 Motif and to the Common Coactivators, GRIP-1 and PGC-1{alpha} J. Biol. Chem., May 26, 2006; 281(21): 14537 - 14546. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Pegorier, C. L. May, and J. Girard Control of Gene Expression by Fatty Acids J. Nutr., September 1, 2004; 134(9): 2444S - 2449S. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Gbaguidi and L. B. Agellon The inhibition of the human cholesterol 7{alpha}-hydroxylase gene (CYP7A1) promoter by fibrates in cultured cells is mediated via the liver x receptor {alpha} and peroxisome proliferator-activated receptor {alpha} heterodimer Nucleic Acids Res., February 11, 2004; 32(3): 1113 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Barbier, D. Duran-Sandoval, I. Pineda-Torra, V. Kosykh, J.-C. Fruchart, and B. Staels Peroxisome Proliferator-activated Receptor {alpha} Induces Hepatic Expression of the Human Bile Acid Glucuronidating UDP-glucuronosyltransferase 2B4 Enzyme J. Biol. Chem., August 29, 2003; 278(35): 32852 - 32860. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Ripp, K. C. Falkner, M. L. Pendleton, V. Tamasi, and R. A. Prough Regulation of CYP2C11 by Dehydroepiandrosterone and Peroxisome Proliferators: Identification of the Negative Regulatory Region of the Gene Mol. Pharmacol., July 1, 2003; 64(1): 113 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jung, M. Fried, and G. A. Kullak-Ublick Human Apical Sodium-dependent Bile Salt Transporter Gene (SLC10A2) Is Regulated by the Peroxisome Proliferator-activated Receptor alpha J. Biol. Chem., August 16, 2002; 277(34): 30559 - 30566. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Post, H. Duez, P. P. Gervois, B. Staels, F. Kuipers, and H. M.G. Princen Fibrates Suppress Bile Acid Synthesis via Peroxisome Proliferator-Activated Receptor-{alpha}-Mediated Downregulation of Cholesterol 7{alpha}-Hydroxylase and Sterol 27-Hydroxylase Expression Arterioscler. Thromb. Vasc. Biol., November 1, 2001; 21(11): 1840 - 1845. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Memon, A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold In Vivo and in Vitro Regulation of Sterol 27-Hydroxylase in the Liver during the Acute Phase Response. POTENTIAL ROLE OF HEPATOCYTE NUCLEAR FACTOR-1 J. Biol. Chem., August 3, 2001; 276(32): 30118 - 30126. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |